Key result
Tropoelastin-targeted MRI agent identifies rupture-prone rabbit plaques with ~58% higher R1 relaxation rates.
Answers are grounded in this paper and cite their sources.
Background: Elastolysis and ineffective elastogenesis favor the accumulation of tropoelastin, rather than cross-linked elastin, in atherosclerotic plaques. We developed gadolinium-labeled tropoelastin-specific magnetic resonance contrast agents for tropoelastin imaging in animal models. Methods and Results: Two peptides, VVGSPSAQDEASPLS and YPDHVQYTHY, were selected to target tropoelastin. In vitro binding, relaxivity, and biodistribution experiments enabled characterization of the probes and selecting the best candidate for in vivo magnetic resonance imaging. Magnetic resonance imaging was performed in atherosclerotic apolipoprotein E–deficient mice and New Zealand white rabbits with stable and rupture-prone plaques using a gadolinium-labeled tropoelastin-specific magnetic resonance contrast agent. In addition, human carotid endarterectomy specimens were imaged ex vivo. The VVGSPSAQDEASPLS-based probe discriminated between tropoelastin and cross-linked elastin (64%±7% versus 1%±2%; P =0.001), had high in vitro relaxivity in solution (r 1-free =11.7±0.6 [mmol/L] −1 s −1 , r 1-bound to tropoelastin =44±1 [mmol/L] − 1 s − 1 ), and favorable pharmacokinetics. In vivo mice vascular enhancement (4 weeks=0.13±0.007 mm 2 , 8 weeks=0.22±0.01 mm 2 , 12 weeks=0.33±0.01 mm 2 ; P <0.001) and R 1 relaxation rate (4 weeks=[0.90±0.01]/s, 8 weeks=[1.40±0.03]/s, 12 weeks=[1.87±0.04]/s; P <0.001) increased with atherosclerosis progression after gadolinium-labeled tropoelastin-specific magnetic resonance contrast agent injection. Conversely, statin-treated (0.13±0.01 mm 2 ; R 1 =[1.37±0.03]/s) and control (0.10±0.005 mm 2 ; R 1 =[0.87±0.05]/s) mice showed less enhancement. Rupture-prone rabbit plaques had higher R 1 relaxation rate compared with stale plaques (R 1 =[2.26±0.1]/s versus R 1 =[1.43±0.02]/s; P =0.001) after administration of the gadolinium-labeled tropoelastin-specific magnetic resonance contrast agent that allowed detection of rupture-prone plaques with high sensitivity (84.4%) and specificity (92.3%). Increased vascular R 1 relaxation rate was observed in carotid endarterectomy plaques after soaking (R 1pre =[1.1±0.26]/s versus R 1post =[3.0±0.1]/s; P =0.01). Ex vivo analyses confirmed the magnetic resonance imaging findings and showed uptake of the contrast agent to be specific for tropoelastin. Conclusions: Magnetic resonance imaging of tropoelastin provides a novel biomarker for atherosclerotic plaque progression and instability.
No takes yet. Share an insight, caveat, or question.
Phinikaridou et al. (2018) studied Atherosclerosis. Gadolinium-labeled tropoelastin-specific magnetic resonance contrast agent vs. Stable plaques (or non-atherosclerotic controls) was evaluated on R1 relaxation rate in rupture-prone versus stable rabbit plaques (p=0.001). A gadolinium-labeled tropoelastin-specific contrast agent identified rupture-prone rabbit plaques with higher R1 relaxation rates than stable plaques.
Synapse has enriched 10 related papers. Consider them for comparative context: